ClinicalTrials.gg
Not yet recruitingNCT07835334SHIELDUpdated Sep 22, 2026

Synthetic Mesh for Prevention of HernIa After opEn Abdomen cLosure stuDy

An interventional study of Definitive Fascial Closure Without Prophylactic Mesh and Prophylactic Onlay Mesh Placement in Open Abdomen, Incisional Hernia and Definitive Fascial Closure, sponsored by Hospital San Juan de Dios Tenerife. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-22.

Sponsored by Hospital San Juan de Dios Tenerife · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The aim of this clinical trial is to evaluate whether placement of a synthetic prophylactic onlay mesh during definitive fascial closure can reduce the incidence of incisional hernia in adult patients managed with an open abdomen approach following emergency surgery.

The main questions it aims to answer are:

  • Does prophylactic mesh placement reduce the incidence of incisional hernia compared with fascial closure without mesh?
  • Does prophylactic mesh placement influence the occurrence of postoperative complications such as evisceration or surgical site infection?

Researchers will compare patients undergoing definitive fascial closure with prophylactic mesh placement to those undergoing fascial closure without mesh in order to determine whether the mesh decreases the incidence of incisional hernia and associated complications.

Participants will:

  • Undergo standard open abdomen management followed by definitive fascial closure.
  • Be randomly assigned to one of the two study groups:

    • Definitive fascial closure without prophylactic mesh.
    • Definitive fascial closure with placement of a synthetic prophylactic onlay mesh.
  • Attend clinical follow-up visits in the general surgery outpatient clinic.
  • Undergo clinical evaluations at 1, 6, and 12 months after surgery, including physical examination and, if necessary, imaging studies to detect incisional hernia or postoperative complications.
Read the detailed description

This study will evaluate the impact of synthetic prophylactic onlay mesh placement during definitive fascial closure in patients managed with an open abdomen approach following emergency surgery.

This is a single-center randomized clinical trial with a 1:1 allocation to two treatment groups: definitive fascial closure with prophylactic mesh and definitive fascial closure without mesh. The study will include adult patients treated in the General Surgery Department of the Hospital Universitario Nuestra Señora de Candelaria who required open abdomen management and in whom definitive fascial closure can be achieved.

The primary outcome will be the incidence of incisional hernia during postoperative follow-up. Secondary outcomes will include the occurrence of evisceration and surgical site complications, including infection, seroma, hematoma, enteroatmospheric fistula, and the need for surgical reintervention.

Patients will undergo protocolized follow-up for at least 12 months after definitive fascial closure through outpatient general surgery visits, including physical examination and imaging studies when necessary.

The purpose of the study is to obtain preliminary evidence regarding the efficacy and safety of prophylactic mesh in this clinical setting, with the aim of optimizing open abdomen management and reducing the incidence of incisional hernia and other abdominal wall complications.

02

Conditions studied

  • Open Abdomen
  • Incisional Hernia
  • Definitive Fascial Closure
  • Emergency Abdominal Surgery
  • Prevention of Incisional Hernia Using Prophylactic Mesh

Browse trials for

Keywords

  • Open abdomen
  • Incisional hernia
  • Prophylactic mesh
  • Definitive fascial closure
  • Emergency surgery
  • Negative pressure wound therapy
  • NPWT
  • Damage control surgery
  • Abdominal wall
  • Onlay mesh
  • Surgical complications
  • Emergency abdominal surgery
03

In context

Incisional Hernia

212 studies on the registry are indexed under Incisional Hernia; 58 are open to participants now.

This study's planned enrollment of 30 is below the median of 110 across 130 interventional studies indexed under Incisional Hernia.

Browse Incisional Hernia studies →

Lead sponsor

Hospital San Juan de Dios Tenerife is the lead sponsor of 4 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients older than 18 years.
  • Patients managed with an open abdomen approach.
  • Patients undergoing definitive fascial closure.

Exclusion criteria

Exclusion Criteria:

  • Patients in whom definitive fascial closure cannot be achieved.
  • Inability to complete clinical follow-up or high likelihood of loss to follow-up (e.g., residence outside the catchment area, lack of outpatient follow-up, etc.)
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • Other
    Definitive Fascial Closure Without Prophylactic Mesh

    Patients will undergo definitive fascial closure following open abdomen management, without placement of prophylactic mesh. Perioperative management and clinical follow-up will be conducted according to the standard practice of the department.

    Procedure: Definitive Fascial Closure Without Prophylactic Mesh

  • Experimental
    Definitive Fascial Closure With Prophylactic Onlay Mesh

    Patients will undergo definitive fascial closure following open abdomen management, with placement of a synthetic, macroporous, non-absorbable prophylactic mesh (Optilene®, B. Braun Surgical S.A.) in the onlay position.

    Device: Prophylactic Onlay Mesh Placement

Interventions

  • ProcedureDefinitive Fascial Closure Without Prophylactic Mesh

    Patients will undergo definitive fascial closure following open abdomen management, without placement of prophylactic mesh.

  • DeviceProphylactic Onlay Mesh Placement

    Following definitive fascial closure in patients undergoing open abdomen management, a medium-density, macroporous, non-absorbable synthetic mesh (Optilene®, B. Braun Surgical S.A.) will be placed in the onlay position as prophylactic reinforcement of the abdominal wall. The procedure will be performed during the definitive surgical intervention according to the standard practice of the General Surgery Department.

06

What researchers measure

Primary outcomes

  1. Incidence of Incisional Hernia

    o evaluate the occurrence of incisional hernia following definitive fascial closure in patients undergoing open abdomen management, comparing patients who receive prophylactic onlay mesh reinforcement with those who do not receive prophylactic mesh.

    Time frame: 12 months following definitive fascial closure.

Secondary outcomes

  1. Burst abdomen rate

    To evaluate the occurrence of fascial dehiscence (burst abdomen) following definitive fascial closure.

    Time frame: 1 month after surgery

  2. Surgical Site Occurrence

    o evaluate the incidence of superficial, deep, or organ/space surgical site complications related to the surgical procedure.

    Time frame: 30 days after surgery

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No — Individual Participant Data (IPD) will not be shared because this is a small single-center exploratory study with a limited sample size. All collected data will remain anonymized and confidential in accordance with applicable data protection regulations.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 22, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07835334
Lead sponsor
Hospital San Juan de Dios Tenerife
Responsible party
Julen Ramon Rodríguez (Principal Investigator, General Surgery, University Hospital of the Nuestra Señora de Candelaria) — Principal investigator
First posted
Sep 22, 2026
Start date
Sep 1, 2026 (estimated)
Primary completion
Sep 1, 2027 (estimated)
Completion
Sep 1, 2027 (estimated)
Last update
Sep 22, 2026

Study contacts

Julen Julen Ramón Rodríguez
Contact
julentxu_92@hotmail.com
34672255215

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion